SGX-listed Hyphens Pharma's Digital Healthtech Unit, DocMed Technology, Enters JV with Owners of Vietnam's Hoang Duc Pharma

SGX-listed Hyphens Pharma International's digital healthtech unit, DocMed Technology, has begun its expansion into Vietnam via a 51:49 joint venture with the equity owners of Hoang Duc, one of the country's leading pharmaceutical and medical supplies distributors. The JV will see the development of a B2B virtual medical hypermart for pharmaceutical supplies in Vietnam, and is an extension of DocMed’s offering in Singapore, POM, which is one of the country's largest B2B medical procurement platforms, with more than $30 million in transactions and 500,000 log-ins for 2022.

Leading the transaction team for Hyphens and DocMed was Jeremiah Huang, Director with Icon Law, with support from Brittany Lau.

For more information, please contact Jeremiah Huang or refer to the media's coverage of the transaction.